GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » EV-to-FCF

Gemina Laboratories (XCNQ:GLAB) EV-to-FCF : -67.44 (As of Mar. 16, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Gemina Laboratories's Enterprise Value is C$83.77 Mil. Gemina Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2024 was C$-1.24 Mil. Therefore, Gemina Laboratories's EV-to-FCF for today is -67.44.

The historical rank and industry rank for Gemina Laboratories's EV-to-FCF or its related term are showing as below:

XCNQ:GLAB' s EV-to-FCF Range Over the Past 10 Years
Min: -67.44   Med: 0   Max: 0
Current: -67.44

XCNQ:GLAB's EV-to-FCF is ranked worse than
100% of 418 companies
in the Biotechnology industry
Industry Median: 3.79 vs XCNQ:GLAB: -67.44

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-16), Gemina Laboratories's stock price is C$1.10. Gemina Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 was C$-0.040. Therefore, Gemina Laboratories's PE Ratio (TTM) for today is At Loss.


Gemina Laboratories EV-to-FCF Historical Data

The historical data trend for Gemina Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories EV-to-FCF Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
EV-to-FCF
- -6.88 -10.08 -12.65

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.61 -12.65 -19.04 -22.78 -24.26

Competitive Comparison of Gemina Laboratories's EV-to-FCF

For the Biotechnology subindustry, Gemina Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gemina Laboratories's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's EV-to-FCF falls into.



Gemina Laboratories EV-to-FCF Calculation

Gemina Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=83.765/-1.242
=-67.44

Gemina Laboratories's current Enterprise Value is C$83.77 Mil.
Gemina Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gemina Laboratories  (XCNQ:GLAB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Gemina Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.10/-0.040
=At Loss

Gemina Laboratories's share price for today is C$1.10.
Gemina Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.040.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Gemina Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Gemina Laboratories Business Description

Traded in Other Exchanges
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
Martin Cronin Director
John Davies Director, Director or Senior Officer of 10% Security Holder, Senior Officer
James Damian Tansey Director

Gemina Laboratories Headlines

No Headlines